Venugopal Palla MD in Huntington, New York

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1991
The Primary Medical Specialty for Venugopal Palla MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 33
PAC (PECOS ID)#: 0446237259
NPI #: 1104995075
NPI Created On: 11/07/2006
NPI Last Updated Listed as: 07/08/2007
Primary Taxonomy Code: 207R00000X
License Number:
2111291
Listed Gender: Male

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
2. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
3. Blood test, clotting time
4. Routine ekg using at least 12 leads including interpretation and report
5. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
9. Anti-clotting management for patient taking warfarin
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Established patient office or other outpatient, visit typically 40 minutes
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent
18. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).